{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05025332",
            "orgStudyIdInfo": {
                "id": "NEU-2591-PTHS-001"
            },
            "organization": {
                "fullName": "Neuren Pharmaceuticals Limited",
                "class": "INDUSTRY"
            },
            "briefTitle": "An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)",
            "officialTitle": "An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)",
            "acronym": "PTHS-001",
            "therapeuticArea": [
                "Rare Diseases"
            ],
            "study": "an-open-label-study-of-oral-nnz-in-pitt-hopkins-syndrome-pths"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-10-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-04-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-04-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-08-24",
            "studyFirstSubmitQcDate": "2021-08-24",
            "studyFirstPostDateStruct": {
                "date": "2021-08-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-03",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Neuren Pharmaceuticals Limited",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A study of the safety, tolerability and pharmacokinetics of NNZ-2591 and measures of efficacy in children and adolescents with Pitt Hopkins Syndrome.",
            "detailedDescription": "The primary purpose of this study is to investigate the safety, tolerability and pharmacokinetics of treatment with NNZ-2591 oral solution in children and adolescents with Pitt Hopkins Syndrome. The secondary purpose is to investigate measures of efficacy. Subjects will receive treatment with NNZ-2591 oral solution (50 mg/mL) doses for a total of 13 weeks."
        },
        "conditionsModule": {
            "conditions": [
                "Pitt Hopkins Syndrome"
            ],
            "keywords": [
                "Pitt Hopkins Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "NNZ-2591",
                    "type": "EXPERIMENTAL",
                    "description": "NNZ-2591 oral solution (50mg/mL) to be administered twice daily dose for 13 weeks.",
                    "interventionNames": [
                        "Drug: NNZ-2591"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "NNZ-2591",
                    "description": "NNZ-2591 oral solution (50mg/mL) to be administered twice daily dose for 13 weeks.",
                    "armGroupLabels": [
                        "NNZ-2591"
                    ],
                    "otherNames": [
                        "Cyclo-L-Glycyl-L-2-Allylproline"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety and Tolerability",
                    "description": "To examine the incidence, severity and frequency of adverse events (AEs), including serious adverse events (SAEs) during treatment with NNZ-2591.",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Pharmacokinetic - Measurement of Cmax",
                    "description": "Maximum observed concentration (Cmax) of NNZ-2591",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Pharmacokinetic - Measurement of AUC",
                    "description": "Area under the concentration-time curve of NNZ-2591",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Pharmacokinetic - Measurement of time to Cmax",
                    "description": "Time to Cmax of NNZ-2591",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Pharmacokinetic - Measurement of t1/2",
                    "description": "Apparent terminal elimination half-life of NNZ-2591",
                    "timeFrame": "13 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Pitt Hopkins syndrome-specific Clinical Global Impression Scale-Overall Improvement (CGI-I)",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Caregiver Impression of Improvement",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Pitt Hopkins syndrome-specific Clinical Global Impression Scales-Domain Improvement",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Pitt Hopkins syndrome-specific Clinical Global Impression Scale-Severity (CGI-S)-Overall and Domain",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Caregiver Top 3 Concerns Likert Scale",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by MacArthur-Bates Communicative Development Inventory (MB-CDI)",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Observer-Reported Communication Ability (ORCA)",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Aberrant Behavior Checklist-2 (ABC-2)",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Child Sleep Habits Questionnaire (CSHQ)",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Gastrointestinal Health Questionnaire (GIHQ)",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Vineland Adaptive Behavior Scales-3, Interview version",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Modified two-minute walk test",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Bayley Scales of Infant Development 4 (BSID 4) motor scale",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Caregiver Diaries",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Quality of Life Inventory-Disability (QI-Disability)",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Exploratory efficacy measurement",
                    "description": "Assessed by Impact of Childhood Neurological Disability (ICND)-Overall quality of life rating",
                    "timeFrame": "13 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Clinical diagnosis of PTHS with a documented disease-causing genetic etiology for the disorder.\n2. Males or females aged 3-17 years.\n3. Body weight of 12kg or higher at screening\n4. Subjects with a Clinical Global Impression- Severity (CGI-S) score of 4 or greater at the Screening visit.\n5. Not actively undergoing regression or loss of skills, defined as no persistent loss of previously acquired developmental skills for a period within 3 months of the Screening visit\n6. Each subject must be able to swallow the study medication provided as a liquid solution.\n7. Caregiver(s) must have sufficient English language skills.\n\nExclusion Criteria:\n\n1. Body weight \\<12kg at screening\n2. Clinically significant abnormalities in safety laboratory tests and vital signs at Screening.\n3. Abnormal QTcF interval or prolongation at Screening.\n4. Any other clinically significant finding on ECG at the Screening visit.\n5. Positive for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) and previous COVID 19 infection with last 12 months that required hospitalization.\n6. Unstable or changes Psychotropic treatment 2 weeks prior to screening\n7. Excluded concomitant treatments.\n8. Actively undergoing regression or loss of skills.\n9. Unstable seizure profile.\n10. Current clinically significant renal conditions and abnormalities\n11. Current clinically significant cardiovascular, hepatic, gastrointestinal, respiratory, endocrine disease, or clinically significant organ impairment.\n12. Current clinically significant hypo- or hyperthyroidism, Type 1 or Type 2 diabetes mellitus requiring insulin (whether well controlled or uncontrolled), or uncontrolled Type 1 or Type 2 diabetes.\n13. Has planned surgery during the study.\n14. History of, or current, cerebrovascular disease or brain trauma.\n15. History of, or current catatonia or catatonia-like symptoms.\n16. History of, or current, malignancy.\n17. Current major or persistent depressive disorder (including bipolar depression).\n18. Significant, uncorrected visual or uncorrected hearing impairment.\n19. Allergy to strawberry.\n20. Positive pregnancy test\n21. Subject is judged by the Investigator or Medical Monitor to be inappropriate for the study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "3 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "James Shaw",
                    "role": "CONTACT",
                    "phone": "+61 427 299 669",
                    "email": "jshaw@neurenpharma.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "James Shaw",
                    "affiliation": "Neuren Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama at Birmingham",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cassandra Newsom",
                            "role": "CONTACT",
                            "phone": "205-934-2352",
                            "email": "Cassandranewsom@uabmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "University of California at San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alison Walmsley",
                            "role": "CONTACT",
                            "phone": "408-334-5630",
                            "email": "alison.walmsley@ucsf.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Children's Hospital Colorado",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Eliana Obando",
                            "role": "CONTACT",
                            "phone": "720-777-5378",
                            "email": "eliana.obando@childrenscolorado.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Rush University Medical Center",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alison Bauman",
                            "role": "CONTACT",
                            "phone": "312-942-2005",
                            "email": "Allison_L_Baumann@rush.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "UT Southwestern",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessica Clark",
                            "role": "CONTACT",
                            "phone": "972-655-4847",
                            "email": "Jessica.Clark@UTSouthwestern.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006985",
                    "term": "Hyperventilation"
                },
                {
                    "id": "D000008607",
                    "term": "Intellectual Disability"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                },
                {
                    "id": "D000019066",
                    "term": "Facies"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000012120",
                    "term": "Respiration Disorders"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000012818",
                    "term": "Signs and Symptoms, Respiratory"
                },
                {
                    "id": "D000019954",
                    "term": "Neurobehavioral Manifestations"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000065886",
                    "term": "Neurodevelopmental Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10036",
                    "name": "Hyperventilation",
                    "asFound": "Pitt Hopkins Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11589",
                    "name": "Intellectual Disability",
                    "asFound": "Pitt Hopkins Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21089",
                    "name": "Facies",
                    "asFound": "Pitt Hopkins Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14957",
                    "name": "Respiration Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15623",
                    "name": "Signs and Symptoms, Respiratory",
                    "relevance": "LOW"
                },
                {
                    "id": "M21826",
                    "name": "Neurobehavioral Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M30644",
                    "name": "Neurodevelopmental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T4569",
                    "name": "Pitt-Hopkins Syndrome",
                    "asFound": "Pitt Hopkins Syndrome",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}